Our Excellence Spotlight series celebrates and showcases the remarkable journeys and achievements of RQM+ employees; the same employees who are committed to technical excellence and make a significant impact on our clients.

🔬 Meet RQM+ Director of Biological Evaluation Consulting, Taryn Meade, in our latest Excellence Spotlight interview!

Jaishankar Kutty, Ph.D. describes her as "elegant, talented, quietly confident, and always understated," but we're not going to be understated here! It's time to deservedly shine the spotlight on Taryn and what she brings to RQM+ and our lab clients.

With a decade in medical device and pharmaceutical development, Taryn stands out as an undeniable expert in biological safety evaluation. Taryn comes to RQM+ from the esteemed Jordi Labs, who was acquired by RQM+ in 2022.

Some highlights 🔦

🥼 Lab Expertise: Taryn's unparalleled skill set in the laboratory is matched only by her deep understanding of bioethics and ISO 10993 standards. Her critical role in guiding RQM+ clients through challenging regulatory landscapes is nothing short of impressive.

🧪 Critical Thinking: With a foundation in chemistry and a knack for logical analysis, Taryn anticipates challenges and produces strategic solutions that ensure product safety and compliance, setting her apart in the biocompatibility field.

📖 A Passion for Learning: Taryn's career trajectory is marked by a relentless pursuit of knowledge, tackling new challenges and expanding her expertise beyond her comfort zone. Learn more in the interview!

🛡️ Bioethical Strength: Above all, Taryn's unwavering commitment to patient safety and ethical compliance underscores her role as an admirable leader. Taryn's exceptional lab prowess not only elevate our lab services team and capabilities, but ensure RQM+ remains at the forefront of delivering industry-leading safety evaluations for our clients.

--

We deliver full lifecycle materials science and chemical characterization capabilities. RQM+ / Jordi Labs is often referred to as the ‘Gold Standard’ in extractable-leachable testing and is held in extremely high regard by the FDA. Our expertise spans from conceptual bench top testing and prototyping through design verification and validation, preclinical testing, and post-market lifecycle management.

Services include:

Material and Chemical Characterization
Toxicological Risk Assessments
Extractable-leachable Analysis
Biological Evaluations
Polymer Investigation
Expert Scientific Consulting Across the Development Lifecycle and Post-Market Phase

Learn more and book a consultation with us here.

--

📹 ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠View and share this clip on LinkedIn.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

📲 ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Follow RQM+ on LinkedIn.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

💼 ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Check out our open positions.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

📚 ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠See on-demand content in our Knowledge Center.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

📝 If you'd like to speak with us directly about how we might be able to support you and your organization, you're welcome to use ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠our contact form⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Live! #39 — Sustaining EU MDR and IVDR certification in the post-market phase - What will it take?

Device Advice by RQM+By RQM+Aug 27, 2021